ArticleDrug design, development and therapy2018

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors.

Haiyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.